A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
Sterman DH, Recio A, Carroll RG, Gillespie CT, Haas A, Vachani A, Kapoor V, Sun J, Hodinka R, Brown JL, Corbley MJ, Parr M, Ho M, Pastan I, Machuzak M, Benedict W, Zhang XQ, Lord EM, Litzky LA, Heitjan DF, June CH, Kaiser LR, Vonderheide RH, Albelda SM, Kanther M.
Sterman DH, et al. Among authors: kaiser lr.
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4456-66. doi: 10.1158/1078-0432.CCR-07-0403.
Clin Cancer Res. 2007.
PMID: 17671130
Clinical Trial.